Cellectis
CLLS
78 hedge funds and large institutions have $251M invested in Cellectis in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 34 reducing their positions, and 10 closing their positions.
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
0.21% less ownership
Funds ownership: 35.87% → 35.67% (-0.21%)
3% less funds holding
Funds holding: 80 → 78 (-2)
19% less capital invested
Capital invested by funds: $308M → $251M (-$57.3M)
37% less call options, than puts
Call options by funds: $524K | Put options by funds: $831K
47% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 34
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
+$21.2M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$17.4M |
| 3 |
BlackRock
New York
|
+$1.67M |
| 4 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$1M |
| 5 |
Citigroup
New York
|
+$872K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$7.71M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.01M |
| 3 |
Morgan Stanley
New York
|
-$2.41M |
| 4 |
CIA
Capital Impact Advisors
Boston,
Massachusetts
|
-$2.22M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
-$1.74M |
CLLS Hedge Fund Activity: Q2 2021 in Review
78 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2021, worth a combined $251M — down 19% from $308M a quarter earlier.
Fund positioning in CLLS was balanced in Q2 2021: 10 funds opened new positions, 10 closed out, 18 added to existing stakes and 34 trimmed.
The largest buyer was Principal Financial Group, opening a new position worth an estimated $21.2M. The largest seller was ARK Investment Management, cutting an estimated $7.71M.
- 78 institutional investors held Cellectis (CLLS) as of Q2 2021, down from 80 in Q1 2021.
- Funds reported $251M of Cellectis stock for Q2 2021, down 19% quarter-over-quarter.
- 10 funds opened new Cellectis positions in Q2 2021 and 10 closed out, a net change of 0 holders.
- The largest Cellectis buyer in Q2 2021 was Principal Financial Group, an estimated $21.2M added.
- The largest Cellectis seller in Q2 2021 was ARK Investment Management, an estimated $7.71M sold.
Based on aggregated 13F filings for Q2 2021.